Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37-Reference-Cited by-同舟云学术

Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37

Published:2019-05-03 Issue: Volume: Page:e12943
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Conti Pio¹^ORCID,Gallenga Carla Enrica²,Ronconi Gianpaolo³,Caraffa Alessandro⁴,Kritas Spyros K.⁵

Affiliation:

1. Immunology Division, Postgraduate Medical SchoolUniversity of Chieti‐Pescara Chieti Italy

2. Department of Biomedical Sciences and Specialist Surgery, Section of OphthalmologyUniversity of Ferrara Ferrara Italy

3. UOS Clinica dei Pazienti del TerritorioPoliclinico Gemelli Rome Italy

4. Department of Pharmacology, School of PharmacyUniversity of Camerino Camerino Italy

5. Department of Microbiology and Infectious DiseasesAristotle University of Thessaloniki Thessaloniki Greece

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12943

Reference52 articles.

1. IL‐1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance;Ballak D. B.;Cytokine,2015

2. The role of mast cells in autoinflammation;Bonnekoh H.;Immunological Reviews,2018

3. Psoriatic skin lesions contain biologically active amounts of an interleukin 1‐like compound;Camp R. D.;Journal of Immunology,1986

4. New concepts in neuroinflammation: Mast cells pro‐inflammatory and anti‐inflammatory cytokine mediators;Caraffa A.;Journal of Biological Regulators and Homeostatic Agents,2018

5. IL‐33, the IL‐1‐like cytokine ligand for ST2 receptor, is a chromatin‐associated nuclear factor in vivo;Carriere V.;Proceedings of the National Academy of Sciences of the United States of America,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines in psoriasis: From pathogenesis to targeted therapy;Human Immunology;2024-07

2. Construction and validation of m6A-related diagnostic model for psoriasis;PeerJ;2024-02-29

3. Controversial Issues of Immunopathogenesis of Psoriasis and Atopic Dermatitis;Annals of the Russian academy of medical sciences;2024-02-29

4. Efficient Loading and Sustained Delivery of Methotrexate Using a Tip-Swellable Microneedle Array Patch for Psoriasis Treatment;ACS Biomaterials Science & Engineering;2024-01-30

5. Interleukin‐37 inhibits desmoglein‐3 endocytosis and keratinocyte dissociation via upregulation of Caveolin‐1 and inhibition of the STAT3 pathway;Journal of the European Academy of Dermatology and Venereology;2023-06-12